Royalty Pharma plc (RPRX) Tops Q2 Revenue Estimate

Go back to Royalty Pharma plc (RPRX) Tops Q2 Revenue Estimate
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 58.05 -1.17 (1.98%)
Previous Close $59.22    52 Week High $3.48 
Open $59.50    52 Week Low $0.80 
Day High $59.58    P/E N/A 
Day Low $58.04    EPS $-1.54 
Volume 1,256,202